Parenteral formulation of dezocine

Details Parenteral formulation of dezocine Parenteral formulation of dezocine

A - Human Necessities

61

K

167/273

A61K 31/135 (2006.01) A61K 47/00 (2006.01)

Patent

CA 1251402

Abstract of the Disclosure Ready-to-use parenteral formulations of Dezocine containing from about 0.2 to about 2.0 percent wt/vol. Dezocine; about 30 to about 45 percent wt/vol. propylene glycol; about 0.5 to about 2.0 percent wt/vol. lactic acid buffered with a pharmaceutically acceptable base to a pH of from about 3.5 to about 5.0 and 0 to 0.02 percent wt/vol. sodium metabisulfite, in water for injection.

490818

Affiliated with

Also associated with

Rating

Parenteral formulation of dezocine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Parenteral formulation of dezocine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Parenteral formulation of dezocine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1276627